• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Fresenius Medical Care AG (FMS)

Equity
Sell: $23.21|Buy: $23.71|Change: 0 (0%)

Open 

$23.42

Previous close 

$23.43

Trade high 

$23.565

Volume 

826,629

Year high 

$27.64

Year low 

$20.02

Dividend yield 

3.72%

Market capitalisation 

$12.47 bn

P/E ratio 

12.19

ISIN 

US3580291066

This share can be held in a Dealing account

Share price

Dividends

PreviousLatest
Record date23/05/202522/05/2026
Ex-dividend date23/05/202522/05/2026
Payment date06/06/202508/06/2026
Amount$0.81497$0.87158

Performance 21/08/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

Total return (%)
Fresenius Medical Care AG 0.00
More...

Company profile

Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourthsof sales, while the balance is generated from medical technology products that enable dialysis treatments.

Sector 

Healthcare

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.